Jab for common illness among over-60s on the horizon after regulatory approval
RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.
Source: inverness-courier.co.uk
📰 Neale Belson News
Neale Belson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Neale Belson. Real-time updates on events, politics, business and more.
Medicines and Healthcare products Regulatory Agency authorises GSK's Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults
GSK plc (LSE/NYSE: GSK) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Arexvy (respiratory syncytial virus vaccine, adjuvanted) for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in ...
Source: pharmiweb.com
Jab for common illness among over 60s on the horizon after regulatory approval
RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.
Source: dailyecho.co.uk